ISMA will feature internationally renowned experts discussing the newest developments in the field of molecular allergology and the impact they will have on allergy diagnosis and therapy.
RHINA will offer the opportunity to share the most updated science in allergy and immunology of the upper airways in a translational “bench to bedside” approach.

An excellent and comprehensive scientific programme will explore the following topics and deliver key learning objectives:

ISMA

o Molecular Diagnosis
o Allergen Structure and Determinants of Allergencity
o Cross-Reactivity and Clinical Relevance of Functional in vitro Tests
o News in Food Allergy
o Allergen Exposure and Quantitation
o Impact of Chemical Modification on Immunological Effects of Allergens
o Lifestyle and Environmental Changes and new allergens
o Novel tools and targets for allergy diagnosis and treatment

RHINA

o Biologicals in CRSwNP
o COVID-19 and Upper Airways: more than olfactory loss
o Immunomodulation and new therapeutic approaches in AR
o The reunion of upper and lower airways
o Nonallergic Rhinitis
o Basic Immunology of CRS
o New Biologicals for Upper Airway diseases: are we there yet?
o Immunology for patient care – the missing link

Joint ISMA-RHINA

o Molecular Approaches to Immunotherapy: what’s new
o Allergology and Covid-19